Association of Apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesity

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1559-1562

  Ferreira, D C ^a   Costa, T F ^a   Aguiar, S L F ^a   Marques, A R S ^a   Ramos, S A ^a   Gomes, K B ^a   Alvarez Leite, J I ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Apo E polymorphism; Metabolic syndrome; Morbid obesity

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; APOLIPOPROTEIN E GENE; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MARKER GENE; METABOLIC SYNDROME X; MORBID OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; APOLIPOPROTEINS E; BODY MASS INDEX; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC;

EID: 79959306519     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.04.035     Document Type: Article

References (33)

1. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
2. Sorensen T.I., Virtue S., Vidal-Puig A. Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects?. Biochim Biophys Acta 2010, 1801:400-404.
3. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:i-xii. 1-253.
4. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008, 31:1283-1291.
5. Kuk J.L., Katzmarzyk P.T., Nichaman M.Z., Church T.S., Blair S.N., Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) 2006, 14:336-341.
6. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation 2005, 112:2735-2752.
7. Soverini V., Moscatiello S., Villanova N., Ragni E., Di Domizio S., Marchesini G. Metabolic syndrome and insulin resistance in subjects with morbid obesity. Obes Surg 2010, 20:295-301.
8. Kolovou G.D., Anagnostopoulou K.K. Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev 2007, 6:94-108.
9. Mahley R.W., Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000, 1:507-537.
10. Cardona F., Morcillo S., Gonzalo-Marin M., Tinahones F.J. The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome. J Clin Endocrinol Metab 2005, 90:2972-2975.
11. Olivieri O., Martinelli N., Bassi A., et al. ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome. Clin Exp Med 2007, 7:164-172.
12. Baroni M.G., Berni A., Romeo S., et al. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med Genet 2003, 4:8.
13. Koch W., Hoppmann P., Schomig A., Kastrati A. Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample. Int J Cardiol 2008, 125:116-117.
14. Bu G., Apolipoprotein E. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009, 10:333-344.
15. Huang Z.H., Reardon C.A., Mazzone T. Endogenous ApoE expression modulates adipocyte triglyceride content and turnover. Diabetes 2006, 55:3394-3402.
16. Gao J., Katagiri H., Ishigaki Y., et al. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 2007, 56:24-33.
17. Kypreos K.E., Karagiannides I., Fotiadou E.H., et al. Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity. FEBS J 2009, 276:5720-5728.
18. Pouliot M.C., Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Bouchard C. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res 1990, 31:1023-1029.
19. Pendse A.A., Arbones-Mainar J.M., Johnson L.A., Altenburg M.K., Maeda N. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res 2009, 50(Suppl):S178-182.
20. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann Clin Biochem 1969, 24.
21. Ingelsson E., Arnlov J., Lind L., Sundstrom J. Metabolic syndrome and risk for heart failure in middle-aged men. Heart 2006, 92:1409-1413.
22. Kajimoto K., Kasai T., Miyauchi K., et al. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 2008, 72:1481-1486.
23. Souza GMAR N.L., Whitthe M.R. Efficient mispriming during apolipoprotein E genotyping. J Brazilian Patol Med Lab 2005, 41:25-28.
24. Azarbad L., Gonder-Frederick L. Obesity in women. Psychiatr Clin North Am 2010, 33:423-440.
25. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
26. Mendes-Lana A., Pena G.G., Freitas S.N., et al. Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study. Braz J Med Biol Res 2007, 40:49-56.
27. Fuzikawa A.K., Peixoto S.V., Taufer M., Moriguchi E.H., Lima-Costa M.F. Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambui Health Aging Study (BHAS). Braz J Med Biol Res 2008, 41:89-94.
28. Kolovou G.D., Anagnostopoulou K.K., Kostakou P., et al. Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease. In Vivo 2009, 23:33-39.
29. Cho S.W., Kang J.Y., Park Y.K., Paek Y.M., Choi T.I. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype. Nutr Res 2009, 29:542-550.
30. Murdoch S.J., Boright A.P., Paterson A.D., et al. LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes. Atherosclerosis 2007, 192:138-147.
31. Profenno L.A., Faraone S.V. Diabetes and overweight associate with non-APOE4 genotype in an Alzheimer's disease population. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:822-829.
32. Elosua R., Demissie S., Cupples L.A., et al. Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res 2003, 11:1502-1508.
33. Li X., Du Y., Huang X. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2003, 2:175-179.